MediWound’s NexoBrid® and EscharEx® to be Highlighted in Presentations at the American Burn Association 49th Annual Meeting
YAVNE, Israel, March 14, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that 6 presentations …